The recent characterization of INSM1 DNA binding sites as super-enhancers in SCLC [27] is consistent with the idea that INSM1 may control global gene expression programs producing a neuroendocrine phenotype in the majority of SCLC. Here, INSM1 is linked to small cell lung carcinoma.